ADVANCED BREAST-CANCER - USE OF RESOURCES AND COST IMPLICATIONS
ADVANCED BREAST-CANCER - USE OF RESOURCES AND COST IMPLICATIONS
复制标题
DOI：
10.1038/bjc.1993.157
复制
发表时间：
1993-04-01
影响因子：
8.8
通讯作者：
RUBENS, RD
中科院分区：
文献类型：
--
作者：
RICHARDS, MA;BRAYSHER, S;RUBENS, RD
Little information is currently available on the use of hospital resources and the resulting costs Of treating any advanced cancer.此类数据可能有助于规划目的和计算旨在降低晚期疾病发生率的措施（例如国家乳腺筛查计划）的成本效益。因此，我们对 1988 年 10 月至 1990 年 12 月期间在盖伊医院肿瘤科就诊并死亡的 50 名晚期乳腺癌患者的医疗记录进行了回顾性分析。记录每位患者的住院时间和主要入院指征，以及门诊就诊人数。 Details of endocrine treatment, chemotherapy and radiotherapy were abstracted as were all radiological and laboratory investigations.计算了每项活动的成本。晚期疾病的中位持续时间为 17 个月（平均 27 个月；范围 7 天至 12 年）。 The mean cost of treatment per patients was calculated to be 7,620 pound (range 317 pound-27,860 pound). Mean duration of in-patient stay was 32 days (0-133) and this accounted for 56% of total costs. The large majority (> 80%) of the time spent as an in-patient was for the care of serious illness rather than for specific antitumour treatment. Cytotoxic drugs accounted for 9% of the total cost, compared with 8% for radiotherapy and 13% for laboratory and radiological investigations.
Little information is currently available on the use of hospital resources and the resulting costs Of treating any advanced cancer. Such data may be useful for planning purposes and for calculating the cost effectiveness of measures designed to reduce the incidence of advanced disease (such as the National Breast Screening Programme). A retrospective analysis of the medical records of 50 patients with advanced breast cancer who attended the Guy's Hospital Oncology Unit and who died between October 1988 and December 1990 has therefore been undertaken. For each patient the duration of in-patient stays and principal indications for admissions were recorded, together with the number of out-patient attendances. Details of endocrine treatment, chemotherapy and radiotherapy were abstracted as were all radiological and laboratory investigations. Costs for each of these activities were calculated.The median duration of advanced disease was 17 months (mean 27 months; range 7 days-12 years). The mean cost of treatment per patients was calculated to be 7,620 pound (range 317 pound-27,860 pound). Mean duration of in-patient stay was 32 days (0-133) and this accounted for 56% of total costs. The large majority (> 80%) of the time spent as an in-patient was for the care of serious illness rather than for specific antitumour treatment. Cytotoxic drugs accounted for 9% of the total cost, compared with 8% for radiotherapy and 13% for laboratory and radiological investigations.